4/A: Omada Health CFO Corrects Ownership Filing
Statement of Changes in Beneficial Ownership (Form 4/A)
Omada Health's Chief Financial Officer, Steven L. Cook, has filed an amended Form 4 to correct previously omitted stock option exercise transactions.
Summary
- Steven L. Cook, Chief Financial Officer of Omada Health, Inc., filed an amended Form 4 (Form 4/A) on July 8, 2026, to restate in its entirety a previous Form 4 filed on June 26, 2026.
- The amendment corrects inadvertently omitted stock option exercise transactions that occurred on June 24, 2026, and June 25, 2026.
- These exercises were part of same-day exercise-and-sale transactions, with the sales having been timely reported in the original Form 4.
- The omission led to an understatement of the beneficial ownership of securities following the sales, which has now been adjusted.
- Specifically, 2,600 shares were exercised on June 24, 2026, at $8.01 per share, and 300 shares were exercised on June 25, 2026, at $8.01 per share.
- Following these corrections, the reported beneficial ownership of common stock is 187,209 shares as of June 25, 2026.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral filing, primarily a procedural correction of an administrative oversight rather than a reflection of new company performance or strategic shifts.
Positives
- The company has demonstrated a commitment to accurate and timely reporting through the filing of an amendment to correct an oversight.
- The correction ensures that beneficial ownership figures are accurately reflected, providing a clearer picture of insider holdings.
- The transactions were executed under a Rule 10b5-1 trading plan, indicating a pre-planned and structured approach to stock transactions by management.
Negatives
- An initial omission in the Form 4 filing led to an inaccurate representation of beneficial ownership, requiring a subsequent amendment.
- The weighted average sale price for the transactions on June 24, 2026, was $19.0173, and on June 25, 2026, was $19.0033, indicating sales at a significant premium to the exercise price.
Risks
- The need for an amendment to a SEC filing can sometimes raise questions about internal controls and reporting processes, although in this case it appears to be a procedural correction.
- The filing does not detail any new risks or changes to existing risk factors for the company.
Future Outlook
The filing does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic direction.
Management Comments
- The Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transactions that were inadvertently omitted from the original filing.
- The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4.
- Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated.
- The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.
- Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.
- The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The correction of an omission, especially concerning stock option exercises and sales, is a procedural matter that aims to maintain transparency. The use of a 10b5-1 plan by Omada Health's CFO aligns with best practices for managing insider stock transactions in a pre-determined manner.
Stakeholder Impact
- Shareholders: Increased transparency regarding insider holdings and transactions, ensuring accurate reporting of beneficial ownership.
- Management: Reinforces the importance of accurate and timely SEC filings and adherence to reporting procedures.
- Regulatory Bodies (SEC): Ensures compliance with Section 16(a) of the Securities Exchange Act of 1934.
Next Steps
- The filing is complete as an amendment to a prior filing.
- No further immediate actions are indicated by this specific filing.
Key Dates
| Date | Description |
|---|---|
| 02/01/2024 | Vesting Commencement Date for stock options. |
| 03/14/2026 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 06/24/2026 | Date of stock option exercise and sale transaction. |
| 06/25/2026 | Date of stock option exercise and sale transaction. |
| 06/26/2026 | Date of original Form 4 filing. |
| 07/08/2026 | Date of amended Form 4/A filing. |
| 02/08/2034 | Expiration date for stock options. |
Keywords
Form 4/A, Omada Health, Steven L. Cook, Stock Options, Beneficial Ownership, SEC Filing, Insider Trading, 10b5-1 Plan, Amendment, Exercise
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.